ABDi Farma

Abdi Farma is a wholly-owned subsidiary of Turkish pharma industry leader Abdi Ibrahim Pharmaceuticals and was established as the marketing authorization holder of all Abdi Ibrahim products aimed at European markets. As of January 2022, Abdi Farma started its second phase of its expansion and organically branching out its operation by opening its subsidiaries Abdi Farma GmbH- in Germany was the first of this expansion followed by Abdi Farma Srl, Italy. Abdi Farma aims to serve European markets with high-quality medicine at an affordable price and will aim to reflect Abdi Ibrahim’s 110 years old experience to its new markets.